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Comparison of real-time elastography and multiparametric MRI for prostate 
cancer detection: A whole-mount step-section analysis 
Abstract 
OBJECTIVE. The purpose of this study was to compare prostate cancer detection rate of real-time 
elastography (RTE) with that of multiparametric MRI to evaluate the advantages and disadvantages of the 
two methods. SUBJECTS AND METHODS. Thirty-nine patients with biopsy-proven prostate cancer 
underwent both RTE and multiparametric MRI to localize prostate cancer before radical prostatectomy. 
RTE was performed to assess prostate tissue elasticity, and hard lesions were considered suspicious for 
prostate cancer. Multiparametric MRI included T2-weighted MRI, diffusion-weighted MRI (DWI), and 
contrast-enhanced MRI (CE-MRI) with an endorectal coil at 1.5 T. After radical prostatectomy, whole-
mount step sections of the prostate were generated, and the prostate cancer detection rates with both 
modalities were analyzed for cancer lesions measuring 0.2 cm 3 or larger. RESULTS. Histopathologic 
examination revealed 61 cancer lesions. RTE depicted 39 of 50 cancer lesions (78.0%) in the peripheral 
zone and 2 of 11 (18.2%) in the transitional zone. Multiparametric MRI depicted 45 of 50 cancer lesions 
(90.0%) in the peripheral zone and 8 of 11 (72.7%) in the transitional zone. Significant differences between 
the two modalities were found for the transitional zone and anterior part in prostates with volumes 
greater than 40 cm3 (p < 0.05). Detection rates for high-risk prostate cancer (Gleason score ≥ 4 and 3) 
and cancer lesions with volumes greater than 0.5 cm3 were high for both methods (93.8% and 80.5% for 
RTE, 87.5% and 92.7% for multiparametric MRI). Volumetric measurements of prostate cancer were more 
reliable with T2-weighted MRI than with RTE (Spearman rank correlation, 0.72 and 0.46). CONCLUSION. 
RTE and multiparametric MRI depicted high-risk prostate cancer with high sensitivity. However, 
multiparametric MRI seems to have advantages in tumor volume assessment and for the detection of 
prostate cancer in the transitional zone and anterior part within prostates larger than 40 cm3. American 
Roentgen Ray Society. 
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Besides being useful for tumor localization, 
prostate imaging provides information about 
tumor volume, extracapsular extension, sem-
inal vesical invasion, and the degree of can-
cer aggressiveness. This information may be 
helpful for choosing the most appropriate 
therapy, especially focal therapy, active sur-
veillance, and watchful waiting [5, 6].
Two imaging modalities have been report-
ed to be reliable for prostate imaging and pros-
tate cancer detection. Real-time elastography 
(RTE) is an ultrasound technique that pro-
vides information about tissue elasticity and 
color codes hard areas, in blue for example 
[7]. Prostate cancer has higher cell and ves-
sel density than the normal surrounding tissue 
and therefore exhibits increased stiffness [8]. 
RTE can be performed under real-time condi-
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O
ne of the key requirements of 
prostate imaging is to support 
clinicians in managing the diag-
nosis of and therapy for prostate 
cancer. The diagnosis of prostate cancer is 
confirmed by histologic examination of sys-
tematic biopsy specimens, but the cancer is 
not usually visualized with systematic biop-
sy [1], and therefore prostate cancer may be 
missed [2]. Most biopsy specimens are ob-
tained from the posterolateral part of the 
prostate; sampling of the anterior regions 
and the transitional zone is not recommend-
ed, especially in the first systematic biopsy 
[1, 3]. Durmus et al. [4] suggest targeted bi-
opsy when multiparametric MRI is per-
formed and novel transrectal ultrasound 
technologies rather than systematic biopsy. 
Keywords: diffusion, elastography, multiparametric MRI, 
perfusion, prostate cancer
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OBJECTIVE. The purpose of this study was to compare prostate cancer detection rate of 
real-time elastography (RTE) with that of multiparametric MRI to evaluate the advantages 
and disadvantages of the two methods.
SUBJECTS AND METHODS. Thirty-nine patients with biopsy-proven prostate can-
cer underwent both RTE and multiparametric MRI to localize prostate cancer before radical 
prostatectomy. RTE was performed to assess prostate tissue elasticity, and hard lesions were 
considered suspicious for prostate cancer. Multiparametric MRI included T2-weighted MRI, 
diffusion-weighted MRI (DWI), and contrast-enhanced MRI (CE-MRI) with an endorectal 
coil at 1.5 T. After radical prostatectomy, whole-mount step sections of the prostate were gen-
erated, and the prostate cancer detection rates with both modalities were analyzed for cancer 
lesions measuring 0.2 cm3 or larger.
RESULTS. Histopathologic examination revealed 61 cancer lesions. RTE depicted 39 
of 50 cancer lesions (78.0%) in the peripheral zone and 2 of 11 (18.2%) in the transitional 
zone. Multiparametric MRI depicted 45 of 50 cancer lesions (90.0%) in the peripheral zone 
and 8 of 11 (72.7%) in the transitional zone. Significant differences between the two modali-
ties were found for the transitional zone and anterior part in prostates with volumes greater 
than 40 cm3 (p < 0.05). Detection rates for high-risk prostate cancer (Gleason score ≥ 4 and 
3) and cancer lesions with volumes greater than 0.5 cm3 were high for both methods (93.8% 
and 80.5% for RTE, 87.5% and 92.7% for multiparametric MRI). Volumetric measurements 
of prostate cancer were more reliable with T2-weighted MRI than with RTE (Spearman rank 
correlation, 0.72 and 0.46).
CONCLUSION. RTE and multiparametric MRI depicted high-risk prostate cancer with 
high sensitivity. However, multiparametric MRI seems to have advantages in tumor volume 
assessment and for the detection of prostate cancer in the transitional zone and anterior part 
within prostates larger than 40 cm3.
Junker et al.
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tions, which is useful for targeted biopsy [9]. 
Multiparametric MRI has been introduced to 
raise the overall diagnostic accuracy in pros-
tate cancer diagnosis by revealing structural 
and functional tissue information that may 
help identify prostate cancer [10]. In multi-
parametric MRI conventional T2-weighted 
sequences are used to assess structural tissue 
information, and at least two functional tech-
niques are added, such as diffusion-weighted 
imaging (DWI) to assess water diffusibility 
and contrast-enhanced MRI (CE-MRI) to as-
sess contrast dynamics [11].
The aim of this study was to test whether—
depending on tumor localization, clinical sig-
nificance, or prostate volume—either RTE or 
multiparametric MRI is superior for the de-
tection of prostate cancer. Although solid data 
from assessments of each modality separately 
exist in the literature, in this study we evalu-
ated both modalities in the same cohort of pa-
tients. We compared diagnostic performance 
and estimation of tumor volume for RTE and 
multiparametric MRI in patients with known 
prostate cancer using prostate whole-mount 
step section as the standard of reference. To 
our knowledge, this is only the second study 
comparing RTE with multiparametric MRI 




From April 2010 to January 2012, 40 patients 
(median age, 62 years; range, 48–75 years) par-
ticipated in this prospective single-center study. 
The median serum prostate-specific antigen con-
centration was 5.2 ng/mL (range, 2.1–14 ng/mL); 
median prostate volume, 31 cm3 (range, 15–130 
cm3); and median time between biopsy and im-
aging, 79 days (range, 40–219 days). A positive 
vote of the local ethics committee and written 
informed consent were obtained. All men had 
biopsy-proven prostate cancer and were sched-
uled for radical prostatectomy at our institution. 
After radical prostatectomy the pathologist pre-
pared the prostates as whole-mount step sections 
and marked the borders of all diagnosed cancer 
lesions. Thirty-nine of the 40 participants under-
went first RTE and then multiparametric MRI the 
day before radical prostatectomy. The excluded 
patient underwent RTE but not MRI because of a 
scheduling conflict. Thirty-eight of the 39 patients 
underwent all three MRI techniques: T2-weighted 
MRI, DWI, and CE-MRI. Because of feeling un-
comfortable during the examination, one patient 
underwent only T2-weighted-MRI and DWI but 
was not excluded from statistical analysis.
62-Time Elastography
RTE was performed by an experienced opera-
tor using a 7.5-MHz end-firing transrectal probe 
and an EUB 8500 ultrasound unit (Hitachi Medi-
cal Systems) to assess tissue elasticity. Images were 
generated by slight prostate compression and de-
compression with the transrectal probe. Hard ar-
eas were color-coded blue and considered suspi-
cious for prostate cancer (Fig. 1). These areas had 
to be reproducible in the axial and sagittal planes 
according to a previously described approach, and 
the diameters in all three orientations were mea-
sured [15]. The operator was blinded to multipara-
metric MRI, clinical, and histopathologic findings.
Multiparametric MRI
Multiparametric MR images were interpreted by 
an experienced reader. MRI was performed with a 
1.5-T system (Avanto, Siemens Healthcare) and a 
six-channel phased-array body coil combined with 
an endorectal coil. After digital rectal examination 
the balloon of the endorectal coil was inflated with 
50 mL of air. A volume calculation for cancer-suspi-
cious lesions was performed on T2-weighted 3D tur-
bo spin-echo with variable flip angle (SPACE, Sie-
mens Healthcare) images with the volumetric tool 
Syngovia (Siemens Healthcare). Each MRI tech-
nique was scored according to how it represented a 
suspicious prostate cancer lesion. The summary of 
these points (3–9 points) was the final score. Lesions 
with more than 5 points were considered to be sus-
picious for cancer. The reader was blinded to RTE, 
clinical, and histopathologic findings.
T2-Weighted MRI
T2-weighted MR images were obtained in the 
axial and sagittal planes with turbo spin-echo 
sequences. The entire prostate and the semi-
nal vesicles were investigated. The axial plane 
was defined by an orientation 90° to the urethra 
to be comparable to the histopathologic slices. A 
SPACE 3D sequence was also performed in the 
coronal plane. The T2-weighted MRI parameters 
are shown in Table 1. Low-signal-intensity nod-
ules or ill-defined low-signal-intensity areas in the 
normally high-signal-intensity peripheral zone or 
low-signal-intensity areas with ill-defined mar-
gins in the transitional zone were considered sus-
picious for prostate cancer [16]. On T2-weighted 
MR images the reader assigned a score to the find-
ings using a 3-point scale: 1, benign; 2, interme-
diate; 3, malignant. All volumetric measurements 
were performed on T2-weighted images, which 
provide the best anatomic information.
Fig. 1—62-year-old 
man with prostate 
cancer. Real-time 
elastogram shows two 
hard lesions (calipers, 
blue) in peripheral zone 
of prostate. D1, D2 = 
diameters of first lesion. 
D3 = long diameter of 
second lesion.
TABLE 1: Parameters for Multiparametric MRI 
Parameter T2 Weighted Diffusion Weighted Dynamic Contrast Enhanced 
Sequence Fast spin-echo Spin-echo echoplanar imaging T1-weighted 3D FLASH
TR 3520 2200 2.83
TE 87 74 1.02
Flip angle (°) 90 90 9
FOV (mm2) 180 × 180 210 × 210 380 × 285
Matrix 25 × 256 128 × 90 256 × 128
Slice thickness (mm) 3 3 4
b value (s/mm2) 50/400/800
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Diffusion-Weighted MRI
DW images were obtained in axial planes with 
echoplanar imaging sequences at three b values 
(50, 400, and 800 s/mm2). Restriction of diffusion 
was quantified by apparent diffusion coefficient 
(ADC) value. The DWI parameters are shown 
in Table 1. On DW images the reader assigned a 
score to imaging findings using a 3-point scale ac-
cording to ADC value: 1, benign at ADC > 1200; 
2, intermediate at ADC 900–1200; 3, malignant at 
ADC < 900 [16].
Contrast-Enhanced MRI
Contrast-enhanced MR images were obtained 
in axial planes with fast 3D T1-weighted volumet-
ric interpolated breath-hold examination (VIBE) 
gradient-echo sequences every 7 seconds for ap-
proximately 10 minutes during continuous injec-
tion of gadolinium contrast material (gadoter-
ate meglumine, Dotarem, Guerbet; flow rate, 0.1 
mL/s). The CE-MRI parameters are shown in Ta-
ble 1. Perfusion curves were generated with the 
Tissue4D program (Siemens Healthcare), which 
calculates a pharmacokinetic model derived from 
the Tofts model. Pharmacokinetic variables, in-
cluding Ktrans and Kep, were determined [16]. Ar-
eas with increased time to peak, increased peak 
enhancement, and increased washout rate were 
considered suspicious for prostate cancer. Asym-
metric hyperperfusion or hyperperfusion within a 
focal lesion was considered highly suspicious. On 
CE-MR images, the reader assigned a score to im-
aging findings using a 3-point scale: 1, benign; 2, 
intermediate; 3, malignant (Fig. 2).
Histopathologic Preparation, Reporting, and 
Correlation With Imaging Findings
After radical prostatectomy and fixation, the 
prostatectomy specimens were laminated in 
4-mm-thick slices with an orientation of 90° to 
the urethra. Pathologic analysis was performed 
by an experienced pathologist, who marked all 
cancer lesions and reported the Gleason score as-
signed. A shrinkage factor of 10% was into ac-
count for assessment of tumor volumes. The pros-
tate of each patient was divided into peripheral 
and transitional zone and into anterior, posterior, 
right, and left parts. The border between the ante-
rior and posterior parts was defined as the imagi-
nary line through the widest transverse diameter 
of the prostate. Only cancer lesions with a volume 
of 0.2 cm3 or more were considered for analysis.
Statistical Analysis and Measurements
For all patients, summary statistics were pro-
vided with the appropriate measures of location 
and measures of variation. Only areas suspicious 
for prostate cancer with a volume of 0.2 cm3 or 
greater were considered for statistical analysis. 
Detection rates including exact 95% CIs were cal-
culated for multiparametric MRI and RTE. The 
Fisher exact test was used for comparison. The 
measurements of tumor volumes were compared 
between histopathologic slices, RTE, and T2-
weighted MRI by Spearman rank correlation and 
exact 95% CIs. All statistical calculations were 
performed with SPSS software (version 18.0, IBM 
SPSS), and p < 0.05 was considered statistically 
significant. All findings of subgroup analyses with 
p > 0.03 (anatomic regions of the prostate, pros-
tate volume, tumor volume, and Gleason score) 
were interpreted as very conservative. Multivari-
ate analysis was performed; all combinations con-
sidered relevant are listed in Table 2.
Results
Histologic examination of the 39 patients 
who underwent prostatectomy revealed 61 can-































Fig. 2—58-year-old man with prostate cancer (arrow) 
in left anterior transitional zone.
A–D, Multiparametric T2-weighted low-signal-
intensity (A) and low apparent diffusion coefficient 
(B) images and washout curve (C) in hyperperfused 
area (D) show lesion. ROI = region of interest.
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er (median, 0.85 cm3; range, 0.2–11.18 cm3), of 
which 50 (82.0%) were localized in the periph-
eral zone, 11 (18.0%) in the transitional zone, 
20 (32.9%) in the anterior part, and 41 (67.2%) 
in the posterior part of the prostate. The medi-
an Gleason score was 7 (range, 5–10).
Prostate Cancer Detection Rates According to 
Localization and Prostate Volume
In total, RTE depicted 41 of 61 cancer le-
sions (67.2%) with a false-positive rate of 
25.5%. Multiparametric MRI depicted 53 of 
61 lesions (86.9%) with a false-positive rate 
of 13.1% (p = 0.017) (Table 2). The com-
bined approach of RTE and MRI depicted 56 
of 61 cancer lesions (91.8%).
When cancer lesions were located in the 
posterior parts of the prostate, there was no 
significant difference in prostate cancer de-
tection rate between RTE (78.0%) and mul-
tiparametric MRI (87.8%) (p = 0.379). A 
significant difference in prostate cancer de-
tection rate was found in the anterior parts 
with an overall sensitivity of 45.0% for RTE 
and 85.0% for multiparametric MRI (p = 
0.019). This difference was mainly caused 
by coexistent transitional zone localization 
or prostate volumes greater than 40 cm3. 
However, no significant difference between 
the two imaging modalities was found when 
anterior cancers were located in the periph-
eral zone (p = 0.471) or in prostates with vol-
umes less than 40 cm3 (p = 0.371) (Table 2). 
Regarding the peripheral zone only, the pros-
tate cancer detection rates for RTE (78.0%) 
and multiparametric MRI (90.0%) did not 
differ significantly (p = 0.171).
Prostate Cancer Detection Rates According to 
Tumor Volumes
Irrespective of tumor volumes, the two mo-
dalities had similar detection rates. No signifi-
cant differences were found. Within each mo-





pn % CI n % CI
Total 61 53 86.9 75.8–94.2 41 67.2 54.0–78.7 0.017
Tumor localization
Anterior 20 17 85.0 62.1–96.8 9 45.0 23.1–68.5 0.019
Posterior 41 36 87.8 73.8–95.9 32 78.0 62.4–89.4 0.379
Transitional zone 11 8 72.7 39.0–94.0 2 18.2 2.3–51.8 0.030
Peripheral zone 50 45 90.0 78.2–96.7 39 78.0 64.0–88.4 0.171
anterior and transitional zone 11 8 72.7 39.0–94.0 2 18.2 2.3–51.8 0.030
anterior and peripheral zone 9 9 100.0 66.3–100 7 77.8 40.0–97.2 0.471
anterior and prostate volume < 40 cm3 12 10 83.3 51.6–97.9 7 58.3 27.7–84.8 0.371
anterior and prostate volume > 40 cm3 8 7 87.5 47.3–99.7 2 25.0 3.2–65.1 0.041
Tumor volume (cm3)
≤ 0.5 20 15 75.0 50.9–91.3 8 40.0 19.1–63.9 0.054
> 0.5 41 38 92.7 80.1–98.4 33 80.5 65.1–91.1 0.194
0.5–1 15 15 100.0 78.2–100 12 80.0 51.9–95.7 0.224
> 1 26 23 88.4 69.8–97.6 21 80.8 60.6–93.4 0.703
Gleason score
5–7 (3 + 4) 45 39 86.7 73.2–94.9 26 57.8 42.2–72.3 0.004
7 (4 + 3) 10 8 80.0 44.4–97.5 9 90.0 55.5–99.7 1.000
8–10 6 6 100.0 54.1–100 6 100.0 54.1–100 1.000
Prostate volume (cm3)
< 40 42 38 90.5 77.4–97.3 33 78.6 63.2–89.7 0.227
> 40 19 15 78.9 54.4–93.9 8 42.1 20.3–66.5 0.045
0





















Fig. 3—Graph shows 
prostate cancer detection 
rate according to tumor 
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dality the detection rates for tumor volumes 
greater than 0.5 cm3 compared with volumes 
of 0.5 cm3 or less differed significantly for 
RTE (p < 0.003) but not for multiparametric 
MRI (p = 0.100) (Fig. 3 and Table 2).
Prostate Cancer Detection According to 
Gleason Score
For high-risk prostate cancer (Gleason 
score ≥ 4 + 3), RTE had a detection rate of 
93.8% and MRI of 87.5% (p = 1.0). A signifi-
cant difference between modalities was found 
for the detection of low-risk prostate cancer 
(Gleason score ≤ 3 + 4) with detection rates 
of 57.8% for RTE and 86.7% for MRI (p = 
0.004). In contrast to that of multiparamet-
ric MRI, the detection rate of RTE within the 
modality was significantly higher for cancer 
lesions with a predominant Gleason pattern ≥ 
4 than for a pattern ≤ 3 (p = 1.000 for multipa-
rametric MRI, p < 0.012 for RTE).
Comparison of Volumetric Measurements
Overall the median cancer volume was 
0.82 cm3 (range, 0.21–11.2 cm3). Spearman 
rank correlation with histopathologic results 
showed a correlation coefficient of 0.72 (CI, 
0.57–0.82) for MRI and 0.46 (CI, 0.24–0.64) 
for RTE. Because the CIs do not cover the 
particular correlation coefficient, this differ-
ence has to be regarded as significant.
Discussion
In general, imaging of prostate cancer is 
limited by tumor volume (size) and grade, 
because cancers with a predominant Gleason 
pattern of 3 (i.e., Gleason score of 6 with 3 + 
3 or of 7 with 3 + 4) are intermixed with nor-
mal glands and glands with dilated lumina 
(sparse tumors) [7, 17, 18]. Delongchamps et 
al. [16] used a similar multiparametric MRI 
setting with an endorectal coil at 1.5 T and 
for prostate cancers with volumes greater 
than 0.2 cm3 reported a sensitivity of 80% 
for the peripheral zone and 53% for the tran-
sitional zone, which are in concordance with 
our results. Furthermore, Yerram et al. [19] 
found that the presence of only low-suspi-
cion lesions at multiparametric MRI can al-
most exclude the presence of high-risk pros-
tate cancer. Delongchamps et al. [20] did not 
miss a single case of high-risk prostate can-
cer in a study of targeted MRI-ultrasound 
fusion biopsy. These data suggest that clini-
cally significant disease can be detected with 
high confidence with imaging techniques 
and that therefore these techniques can be re-
liable tools for clinicians dealing with pros-
tate cancer diagnosis and therapy. Therefore, 
the most important issue of this study was to 
compare RTE and multiparametric MRI re-
garding their accuracy in detection and char-
acterization of clinically significant disease.
Tumor volume is one important factor for 
defining significant disease. We found com-
parably high detection rates for prostate can-
cers with volumes greater than 0.5 cm3 for 
both RTE (80.5%) and multiparametric MRI 
(92.7%) (Fig. 4). In accordance with the stud-
ies by Sumura et al. [14] and Roethke et al. 
[18] dealing with detection rates in relation 
to tumor volume, in our study both modali-
ties had increasing accuracy for prostate can-
cer detection with increasing tumor volume. 
Sumura et al., to our knowledge the first study 
group to evaluate RTE and MRI in the same 
patient population, found superiority for RTE 
in the detection of small cancer lesions com-
pared with T2-weighted MRI and CE-MRI 
separately. In comparison with their findings, 
our results suggest that combining T2-weight-
ed MRI, CE-MRI, and DWI increases sensi-
tivity for the detection of small cancer lesions 

































Fig. 4—65-year-old man with prostate cancer.
A–F, Axial real-time elastogram (A), T2 -weighted low-signal intensity (B), and low apparent diffusion coefficient (C) MR images, washout curve (E) in hyperperfused 
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our observation that the diagnostic accuracy 
of RTE was more dependent on tumor size 
than was the accuracy of MRI. This agrees 
with our observation that Spearman rank cor-
relation was 0.72 for multiparametric MRI 
and only 0.46 for RTE in comparisons of vol-
ume measurements of cancer lesions with the 
histopathologic findings.
According to our findings, multiparamet-
ric MRI seems more reliable for tumor vol-
ume assessment. Thus for active surveillance 
of suspicious lesions and for follow-up exam-
inations to detect tumor growth, MRI seems 
to be more reliable. This is in line with the 
findings of Curiel et al. [21], who investigat-
ed an ultrasonic elastographic imaging sys-
tem that may provide a simple and cost-ef-
fective solution to monitoring high-intensity 
focused ultrasound treatments [21]. They as-
sessed the volume of high-intensity focused 
ultrasound lesions in prostates and found that 
in general tumor volume was underestimated 
with elastography in comparison with MRI.
Regarding tumor histology, in the cur-
rent study comparably high rates of detection 
of high-risk prostate cancer were found for 
RTE with (93.8%) and multiparametric MRI 
(87.5%). The one case of high-risk prostate 
cancer missed with RTE was located in the 
transitional zone, and the two cases missed 
with multiparametric MRI were not visible 
because of artifacts of the endorectal coil. Pel-
zer et al. [12], who also compared RTE find-
ings with multiparametric MRI findings for 
prostate cancer diagnosis, found a reduced 
rate of detection of low-risk prostate cancer 
for both methods compared with detection of 
high-risk prostate cancer. Slightly different 
from these findings, in our study population 
with low serum prostate-specific serum con-
centrations, multiparametric MRI was supe-
rior to RTE for visualization of low-risk pros-
tate cancer (86.7% for multiparametric MRI 
and 57.8% for RTE; p < 0.005). This finding 
might have occurred because RTE alone can 
provide information about tissue hardness 
only. In contrast, multiparametric MRI re-
veals structural and tissue perfusion informa-
tion. The usefulness of combining RTE with 
contrast-enhanced ultrasound has been found 
in previous studies [6, 22].
Like those of Pelzer et al. [12], our results 
suggest that multiparametric MRI may have 
advantages in the detection of transitional zone 
cancers. The sensitivities were 72.7% for mul-
tiparametric MRI and 18.2% for RTE (p < 
0.05). MRI also seems superior for visualiza-
tion of anterior cancers located in prostates 
with a volume greater than 40 cm3. These re-
sults may be explained by cancer localization 
and the technical limits of RTE: All transi-
tional zone cancers were highly anterior, and 
when calcifications were simultaneously lo-
cated in the posterior parts of the transitional 
zone, there was no possibility of reaching these 
regions for RTE and ultrasound. In general this 
is due to hardening artifacts. In addition, inves-
tigation of the transitional zone and anterior 
parts in prostates with benign prostatic hyper-
trophy is limited for RTE because of stiffness 
artifacts of the inner gland [23]. However, RTE 
showed no significant difference in the detec-
tion of these tumors compared with multipara-
metric MRI when anterior cancers were locat-
ed in prostates with a volume less than 40 cm3 
(p = 0.37) or in the peripheral zone only (p = 
0.45). This observation was also made for the 
dorsal parts of the peripheral zone (p = 0.38) 
in comparisons of the two modalities. More-
over, with one exception all transitional zone 
cancers were low-risk cancers, and significant 
differences in prostate cancer detection be-
tween RTE and multiparametric MRI in these 
regions existed only for cancer lesions 0.5 cm3 
and smaller. These findings suggest that in-
vestigation of the inner gland and of anterior 
regions of the prostate, although less reliable 
than MRI, can be accurately performed with 
RTE in prostates with a volume less than 40 
cm3 and for detection of high-risk tumors by a 
skilled investigator.
Our study had several limitations. We did 
not have data about intraobserver and interob-
server variability for the two methods. Sec-
ond, we focused this study on correlation with 
histopathologic whole-mount step sections, 
and because only patients with confirmed 
cancer undergo radical prostatectomy it was 
not possible to perform a correlation with 
negative results. Third, for the same reason, 
we knew that every patient had prostate can-
cer, which is a bias. Fourth, there was no di-
rect image-to-image registration for the origi-
nal datasets. Therefore, we are not ultimately 
sure whether the identical geographic areas 
were compared for volumetric analysis. Fifth, 
in some patients the endorectal coil used for 
multiparametric MRI caused extinction arti-
facts in posterior regions of the prostate. Thus 
two cancer lesions were missed with multipa-
rametric MRI that may have been detected 
without the endorectal coil. Sixth, MRI was 
performed in a multiparametric way, whereas 
ultrasound was performed with RTE alone. A 
prospective comparison between multipara-
metric MRI and multiparametric ultrasound 
(i.e., B-mode, contrast-enhanced ultrasound, 
and RTE) would be interesting. The final 
three limitations were the modest sample size, 
performance of a single evaluation of all indi-
viduals (reproducibility is unknown) and sin-
gle pathologist observer, and the variable time 
between biopsy and imaging.
Summarizing our results and consider-
ing that in contrast to multiparametric MRI, 
RTE is a cost-effective and noninvasive tech-
nique that can be performed under real-time 
conditions, the integration of the two meth-
ods in clinical routine can be achieved as 
proposed by Heijmink et al. [24]: Because 
RTE has similar good reliability for the di-
agnosis of high-risk cancer, it seems suffi-
cient for screening purposes and for initial 
biopsies, in which RTE-targeted cores can 
be obtained in addition to systematic cores. 
Several studies have shown that this com-
bined approach may raise the overall sensi-
tivity in prostate cancer diagnosis [9, 25]. If 
biopsy results are negative but there is ongo-
ing suspicion of prostate cancer, the limita-
tions of RTE, especially for the detection of 
transitional zone tumors and anteriorly locat-
ed tumors in prostates with benign prostatic 
hypertrophy, should be remembered. These 
patients then may undergo multiparametric 
MRI to achieve the high sensitivity of the 
combined approach as found in this study. If 
lesions suspicious for being prostate cancer 
are found at multiparametric MRI, they can 
be biopsied with multiparametric MRI tar-
geting or with cognitive or technical fusion 
by means of ultrasound [26–28].
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